Suggestions
Patrick Vollmar
Brand Director & HCP Experience Lead Ligelizumab - Launch in Chronic Spontaneous Urticaria
Dr. Patrick Vollmar is a seasoned global strategic leader in the pharmaceutical industry, with over 10 years of experience focusing on putting people first.
His expertise lies in expanding marketing and sales leadership roles, creating high-performing teams, and successfully launching blockbuster drugs like Gilenya and Aimovig, making history in CNS launches.
With a background in Neuroscience and a track record in scientific research, Dr. Vollmar has excelled in various positions at Novartis, including serving as Brand Director for significant launches and holding strategic roles in areas like neuroscience and multiple sclerosis.
His educational journey includes a PhD in Neuroimmunology with summa cum laude honors from Technische Universität München, an MSc in Psychology with a focus on Neuroscience and neuropsychology from Ruhr-Universität Bochum, and other academic pursuits at renowned institutions.
